GSTT SEMINAR: Dr Hitesh Mistry, University of Manchester - A serious division in drug cardiac toxicity
12:00pm - 1:00pm /
Monday 1st February 2016
/ Venue: Lecture Theatre 2 Life Sciences Building
- Louise Crompton
- Suitable for: All welcome. Registration not required.
- Book now
Add this event to my calendar
Click on "Create a calendar file" and your browser will download a .ics file for this event.
Microsoft Outlook: Download the file, double-click it to open it in Outlook, then click on "Save & Close" to save it to your calendar. If that doesn't work go into Outlook, click on the File tab, then on Open & Export, then Open Calendar. Select your .ics file then click on "Save & Close".
Google Calendar: download the file, then go into your calendar. On the left where it says "Other calendars" click on the arrow icon and then click on Import calendar. Click on Browse and select the .ics file, then click on Import.
Apple Calendar: The file may open automatically with an option to save it to your calendar. If not, download the file, then you can either drag it to Calendar or import the file by going to File >Import > Import and choosing the .ics file.
Hitesh is a researcher, working in pharmacology, currently in academia, alongside pharmaceutical companies, using real world data from oncology departments within hospitals and cancer research UK centres.
In addition to this, Hitesh is also a consultant for AstraZeneca, Physiomics and SEDA Pharmaceutical Development Services.
Hitesh has also worked in industry proper and in 2012 Hitesh was awarded the AstraZeneca Oncology Innovation Award for developing a transnational Prostate Cancer model. When at AstraZeneca Hitesh was an instrumental part of a UK 3 R’s team award for developing a predictive cardiac toxicity model.
Trained in mathematics, Hitesh uses mathematical/statistical models to help inform key decisions during drug development and influencing clinical practice. This has involved building process disruptive predictive models using a variety of algorithms from regression analysis to systems models to multi-model methods. Hitesh has also developed a strong interest in data visualization of high dimensional time-series data as this type of data is now being routinely collected in clinical trials and general clinical practice. His current interests lie both within this area of high-dimensional clinical time-series data-sets but also in smaller more biologically focused data-sets generated within pre-clinical drug development.
In addition to this, Hitesh is also a consultant for AstraZeneca, Physiomics and SEDA Pharmaceutical Development Services.
Hitesh has also worked in industry proper and in 2012 Hitesh was awarded the AstraZeneca Oncology Innovation Award for developing a transnational Prostate Cancer model. When at AstraZeneca Hitesh was an instrumental part of a UK 3 R’s team award for developing a predictive cardiac toxicity model.
Trained in mathematics, Hitesh uses mathematical/statistical models to help inform key decisions during drug development and influencing clinical practice. This has involved building process disruptive predictive models using a variety of algorithms from regression analysis to systems models to multi-model methods. Hitesh has also developed a strong interest in data visualization of high dimensional time-series data as this type of data is now being routinely collected in clinical trials and general clinical practice. His current interests lie both within this area of high-dimensional clinical time-series data-sets but also in smaller more biologically focused data-sets generated within pre-clinical drug development.